Real World Experience with use of Coagulation Factor VIIa at an Academic Medical Center

Background Eptacog alfa and eptacog beta are recombinant factor VIIa (rFVIIa) agents approved for use in hemophilia A or B with inhibitors. Our institution converted from eptacog alfa to eptacog beta as the preferred rFVIIa product. The objective of this medication use evaluation was to review the u...

Cijeli opis

Bibliografski detalji

Glavni autori:	Alyssa R. George PharmD, BCPS, CACP, Katelyn W. Sylvester PharmD, BCPS, CACP, Dareen M. Kanaan PharmD, MPH, BCCP, Prabashni Reddy PharmD, MMedSc, John R. Fanikos BS, MBA, Jean M. Connors MD, Nathan T. Connell MD, MPH
Format:	Artigo
Jezik:	Inglês
Izdano:	SAGE Publishing 2025-12-01
Serija:	Clinical and Applied Thrombosis/Hemostasis
Online pristup:	https://doi.org/10.1177/10760296251405425
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!